1312 Warfarin-related nephropathy in two patients with mechanical valves
Abstract Background and Aims Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical valves required long-term anticoagulant therapy, and warfarin remains the sole available option for anticoagulant therapy....
Saved in:
Published in | Nephrology, dialysis, transplantation Vol. 39; no. Supplement_1 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
23.05.2024
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background and Aims
Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical valves required long-term anticoagulant therapy, and warfarin remains the sole available option for anticoagulant therapy. Consequently, patients with mechanical valves constitute a special group among the entire anticoagulant population.
Method
The present study recorded two patients receiving warfarin therapy for mechanical valve presented to the hospital with gross hematuria and progressive creatinine levels.
Results
The first patient was a 56-year-old female, who had previously undergone mechanical aortic valve replacement surgery nine months ago and was prescribed warfarin, was admitted to the hospital due to the occurrence of gross hematuria six days before hospitalization. Additionally, her creatinine levels exhibited a rapid increase from 120.5umol/L to 207.5 μmol/L within three days. Laboratory analysis revealed a creatinine level of 167.8 μmol/L, albumin level of 39.6 g/L, and an INR value of 2.08. The urinary test results indicated the presence of urinary protein (+) and urinary occult blood (3+). The quantification of urinary protein over a 24-hour period was measured at 0.69 g. The immunoglobulin, complements, ANA, ANCA, anti-GBM antibody, serum protein electrophoresis, serum light chains and PLAR2 were within normal range. The second patient was a 63-year-old male, who has been diagnosed with hypertension for the twenty years, underwent Bentall+Sun's surgery for type A aortic dissection five years ago. Following the surgery, the patient was prescribed warfarin. The patient was admitted to the hospital due to persistent gross hematuria for a duration of twenty days and an increase in creatinine levels. Upon admission, laboratory analysis revealed a creatinine level of 169.9μmol/L (which was within the normal range one year ago), and an INR of 2.69. The urinary test indicated the presence of urinary protein (2+) and urinary occult blood (3+). Urinary protein quantification was 3.06 g/24 hours. The serum IgA level was measured at 4.55 g/L (normal range: 1.0-4.2 g/L). The complements, ANA, ANCA, anti-GBM antibody, serum protein electrophoresis, serum light chains and PLAR2 were within normal range. Pathology of two patients all showed red blood casts and tubular injury consistent with ARN and underlying IgA nephropathy (Fig. 1). The two patients was administered a daily dosage of 20 mg of prednisolone and an oral dosage of 50 mg of cyclophosphamide every other day. During a subsequent follow-up after a two-month period, the first patient's creatinine had decreased to 109.2μmol/L, and the urine protein quantification was recorded as 119.7 mg/24 hours. The second patient's creatinine had decreased to 159.2 μmol/L, and the quantification of urine protein was recorded at 310 mg/24 hours.
Conclusion
Clinicians should maintain a state of increased alertness with regards to the potential occurrence of WRN who exhibit hematuria and elevated creatinine levels while on warfarin therapy, even if their INR remains within the normal range. Considering most patents of WRN have an underlying glomerular disease (mostly IgA nephropathy), the use of steroids and immunosuppressive drugs may appear to be an attractive option, particularly in patients who are unable to replace warfarin with direct oral anticoagulants (NOACs). |
---|---|
AbstractList | Abstract
Background and Aims
Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical valves required long-term anticoagulant therapy, and warfarin remains the sole available option for anticoagulant therapy. Consequently, patients with mechanical valves constitute a special group among the entire anticoagulant population.
Method
The present study recorded two patients receiving warfarin therapy for mechanical valve presented to the hospital with gross hematuria and progressive creatinine levels.
Results
The first patient was a 56-year-old female, who had previously undergone mechanical aortic valve replacement surgery nine months ago and was prescribed warfarin, was admitted to the hospital due to the occurrence of gross hematuria six days before hospitalization. Additionally, her creatinine levels exhibited a rapid increase from 120.5umol/L to 207.5 μmol/L within three days. Laboratory analysis revealed a creatinine level of 167.8 μmol/L, albumin level of 39.6 g/L, and an INR value of 2.08. The urinary test results indicated the presence of urinary protein (+) and urinary occult blood (3+). The quantification of urinary protein over a 24-hour period was measured at 0.69 g. The immunoglobulin, complements, ANA, ANCA, anti-GBM antibody, serum protein electrophoresis, serum light chains and PLAR2 were within normal range. The second patient was a 63-year-old male, who has been diagnosed with hypertension for the twenty years, underwent Bentall+Sun's surgery for type A aortic dissection five years ago. Following the surgery, the patient was prescribed warfarin. The patient was admitted to the hospital due to persistent gross hematuria for a duration of twenty days and an increase in creatinine levels. Upon admission, laboratory analysis revealed a creatinine level of 169.9μmol/L (which was within the normal range one year ago), and an INR of 2.69. The urinary test indicated the presence of urinary protein (2+) and urinary occult blood (3+). Urinary protein quantification was 3.06 g/24 hours. The serum IgA level was measured at 4.55 g/L (normal range: 1.0-4.2 g/L). The complements, ANA, ANCA, anti-GBM antibody, serum protein electrophoresis, serum light chains and PLAR2 were within normal range. Pathology of two patients all showed red blood casts and tubular injury consistent with ARN and underlying IgA nephropathy (Fig. 1). The two patients was administered a daily dosage of 20 mg of prednisolone and an oral dosage of 50 mg of cyclophosphamide every other day. During a subsequent follow-up after a two-month period, the first patient's creatinine had decreased to 109.2μmol/L, and the urine protein quantification was recorded as 119.7 mg/24 hours. The second patient's creatinine had decreased to 159.2 μmol/L, and the quantification of urine protein was recorded at 310 mg/24 hours.
Conclusion
Clinicians should maintain a state of increased alertness with regards to the potential occurrence of WRN who exhibit hematuria and elevated creatinine levels while on warfarin therapy, even if their INR remains within the normal range. Considering most patents of WRN have an underlying glomerular disease (mostly IgA nephropathy), the use of steroids and immunosuppressive drugs may appear to be an attractive option, particularly in patients who are unable to replace warfarin with direct oral anticoagulants (NOACs). |
Author | Xu, Fengbo Wang, Guoqin Sun, Lijun Cheng, Hong Wang, Yanyan Kong, Lingqiang |
Author_xml | – sequence: 1 givenname: Fengbo surname: Xu fullname: Xu, Fengbo – sequence: 2 givenname: Guoqin surname: Wang fullname: Wang, Guoqin – sequence: 3 givenname: Lijun surname: Sun fullname: Sun, Lijun – sequence: 4 givenname: Yanyan surname: Wang fullname: Wang, Yanyan – sequence: 5 givenname: Lingqiang surname: Kong fullname: Kong, Lingqiang – sequence: 6 givenname: Hong surname: Cheng fullname: Cheng, Hong |
BookMark | eNot0DFrwzAUBGBRUqiTdu-oP-Dkyc-2rLGEtgkEugQ6Gll6ql0c2UgmIf--Ds10HBw3fEu28IMnxl4FrAUo3Hg7bX6cJijVWlQgH1gi8hLSDKtiwZJ5IlIoQD2xZYy_AKAyKRO2Eygy_q2D06HzaaBeT2S5p7ENw6in9so7z6fLwOfSkZ8iv3RTy09kWu07o3t-1v2Z4jN7dLqP9HLPFTt-vB-3u_Tw9bnfvh1SU6FMjUMF2BglGy1ojqKExpYSKklWZQJIFhlQhoi5cgqtbUyDthSIJne6xBWD_1sThhgDuXoM3UmHay2gvkHUM0R9h6hvEPgHjb9U2Q |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1093/ndt/gfae069.1807 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2385 |
ExternalDocumentID | 10_1093_ndt_gfae069_1807 |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 0R~ 123 18M 1TH 29M 2WC 4.4 482 48X 53G 5RE 5VS 5WA 5WD 70D AABZA AACZT AAHTB AAJKP AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAVAP AAYXX ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPEJ ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DILTD DU5 D~K E3Z EBS EE~ ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KAQDR KOP KQ8 KSI KSN M-Z MHKGH N9A NGC NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX RUSNO RW1 RXO SDH TCURE TEORI TJX TR2 WH7 WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 |
ID | FETCH-LOGICAL-c837-cf3903bc97ba1ec97560bd67087ed9210e7520e233349f93ddbcb3d6133c4fa63 |
ISSN | 0931-0509 |
IngestDate | Thu Sep 12 17:53:34 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c837-cf3903bc97ba1ec97560bd67087ed9210e7520e233349f93ddbcb3d6133c4fa63 |
OpenAccessLink | https://academic.oup.com/ndt/article-pdf/39/Supplement_1/gfae069-1807-1312/57792867/gfae069-1807-1312.pdf |
ParticipantIDs | crossref_primary_10_1093_ndt_gfae069_1807 |
PublicationCentury | 2000 |
PublicationDate | 2024-05-23 |
PublicationDateYYYYMMDD | 2024-05-23 |
PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-23 day: 23 |
PublicationDecade | 2020 |
PublicationTitle | Nephrology, dialysis, transplantation |
PublicationYear | 2024 |
SSID | ssj0009277 |
Score | 2.4740589 |
Snippet | Abstract
Background and Aims
Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin.... |
SourceID | crossref |
SourceType | Aggregation Database |
Title | 1312 Warfarin-related nephropathy in two patients with mechanical valves |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-QwEA-egtzL4Sd6p5IHX0SqaZNtmkcR10VREFdcn0rTprJyl1VpT_Cvd_LR7e6ioL5025AO3c6vk0kmvxmEdnOhMhi4ldVAwMJCBDKXZaB4ZpiZDHxyw0a-uIx7N-xs0Bm0W4csu6SSB_nru7yS72gV2kCvhiX7Bc2OhUIDnIN-4QgahuOndBzSMNq_zZ5LmPDqwNJSTDRfPZraB-DaWU5f9TJqsqd6Kts_Zei-VjvwNP_9LsKHJo-TubuhsBhaiclZYs4rmwf9b6ano_eD2jrASt_LUbs870zIaT16Go57XteO5zB8qPVszzswSh6ofg0iYiZ87mjCzWIiDQOTScaNKs6UsphAJ1eQp7G1LnGRx5StW2oXQdPwXWvuMl3pAoaj7n2ZKRKLgzBxVXKnU2fPDGnjjYYuxE5TkJF6CamR8AMtRFx0zGz9_KpNLy8iW6pz_Hd8XBuuD0HC4eQzTPgxEw5Jfwn98jMJfORgsYzmlF5Bixd-r8Qq6hl04Fl04Al04KHGgA7coAMbdOAWHdihYw31uyf9417g62YEeUJ5kJdUECpzwWUWKvgBp1YWMScJV4WAKb7inYioiFLKRCloUcDXSQvw62jOyiym62hej7TaQJh3yiRmBDwYwhiNpcw54dBEQilYnNBNtNe8hPTRZUdJP3rlv7_Q9w_62cJsC81Xz7XaBuevkjtWYW_KmFuc |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1312+Warfarin-related+nephropathy+in+two+patients+with+mechanical+valves&rft.jtitle=Nephrology%2C+dialysis%2C+transplantation&rft.au=Xu%2C+Fengbo&rft.au=Wang%2C+Guoqin&rft.au=Sun%2C+Lijun&rft.au=Wang%2C+Yanyan&rft.date=2024-05-23&rft.issn=0931-0509&rft.eissn=1460-2385&rft.volume=39&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Fndt%2Fgfae069.1807&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ndt_gfae069_1807 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0931-0509&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0931-0509&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0931-0509&client=summon |